CDK5 and prostate cancer: CDK5 has been reported to be upregulated in prostate cancer, breast cancer, medullary thyroid carcinoma, pituitary adenoma, and hepatocellular carcinoma, and CDK5 gene amplification was found in lung cancer [11–16].